Media Summary: Prof. Thomas Rades, University of Copenhagen, talks about polymers and small molecules in the process of Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ... In this webinar, Sreehari Babu, Sr. Vice President — Formulations Solutions at Aragen Life Sciences, deep dives into how ...
Stabilizing Amorphous Drugs - Detailed Analysis & Overview
Prof. Thomas Rades, University of Copenhagen, talks about polymers and small molecules in the process of Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ... In this webinar, Sreehari Babu, Sr. Vice President — Formulations Solutions at Aragen Life Sciences, deep dives into how ... Drug molecules with poor water solubility or limited bioavailability present significant clinical challenges. One solution is to ... For more information, visit www.austinpx.com/kinetisol The KinetiSol™ Technology generates For Dr. Frank Romanski, it is important to understand that solid
Dr. Frank Romanski speaks about the the role of excipient selection and key characteristics in Disruptive Materials Pharma have developed a proprietary drug delivery platform based on the MMC material platform, the ... Dr. David Elder, Externalization Director on his perspective on the use of
![David Elder, GSK: Drug Discovery [Part 4] The Rise of Amorphous](https://i.ytimg.com/vi/1zJPvbFY7XM/mqdefault.jpg)